Clinical outcomes and risk factors for SARS-CoV-2 breakthrough cases following vaccination with BNT162b2, CoronaVac, or ChAdOx1-S: A retrospective cohort study in Malaysia

Background: The SARS-CoV-2 pandemic drove global vaccination. However, breakthrough infections raised concerns about vaccine performance, leading the World Health Organization (WHO) to recommend investigations thereof. This study aimed to evaluate the clinical outcomes (time to breakthrough infectio...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Hessa Tamim, Rosnani Hashim, Nurdiana Jamil, Li Yin Chong, Zainol Johari
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Subjects:	SARS-CoV-2 COVID-19 COVID-19 vaccines Breakthrough infection BNT162B2 CoronaVac
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024056056